XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
The September 2019 Offering [Member]
Common Stock [Member]
The September 2019 Offering [Member]
Additional Paid-in Capital [Member]
The September 2019 Offering [Member]
Retained Earnings [Member]
The September 2019 Offering [Member]
The October 2020 Offering [Member]
Common Stock [Member]
The October 2020 Offering [Member]
Additional Paid-in Capital [Member]
The October 2020 Offering [Member]
Retained Earnings [Member]
The October 2020 Offering [Member]
AOCI Attributable to Parent [Member]
The October 2020 Offering [Member]
Placement Agents' Designees [Member]
Common Stock [Member]
Placement Agents' Designees [Member]
Additional Paid-in Capital [Member]
Placement Agents' Designees [Member]
Retained Earnings [Member]
Placement Agents' Designees [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balances (in shares) at Dec. 31, 2019                           48,254,994        
Balances at Dec. 31, 2019                           $ 5 $ 129,608 $ (116,661)   $ 12,952
Issuance of common stock upon exercise of common stock warrants (in shares)                           19,726,120        
Issuance of common stock upon exercise of common stock warrants                           $ 2 10,347 0   $ 10,349
Issuance of common stock upon exercise of stock options (in shares)                           23,606       23,606
Issuance of common stock upon exercise of stock options                           $ 0 18 0   $ 18
Stock-based compensation                           0 96 0   96
Net loss                           $ 0 0 (1,297)   (1,297)
Issuance of common stock, pre-funded warrants and common stock warrants, net of offering costs (in shares) 4,000,000                                  
Issuance of common stock, pre-funded warrants and common stock warrants, net of offering costs $ 0 $ 8,722 $ 0 $ 8,722                            
Issuance of common stock warrants to placement agents’ designees                   $ 0 $ 453 $ 0 $ 453          
Balances (in shares) at Mar. 31, 2020                           72,004,720        
Balances at Mar. 31, 2020                           $ 7 149,244 (117,958)   31,293
Balances (in shares) at Dec. 31, 2020                           110,271,093        
Balances at Dec. 31, 2020                           $ 11 272,274 (148,881) $ 0 123,404
Issuance of common stock (in shares)         6,654,367                          
Issuance of common stock         $ 1 $ 65,711 $ 0 $ 0 $ 65,712                  
Issuance of common stock upon exercise of common stock warrants (in shares)                           830,722        
Issuance of common stock upon exercise of common stock warrants                           $ 0 1,649 0 0 $ 1,649
Issuance of common stock upon exercise of stock options (in shares)                           207,730       207,730
Issuance of common stock upon exercise of stock options                           $ 0 231 0 0 $ 231
Stock-based compensation                           0 1,251 0 0 1,251
Unrealized loss on available-for-sale investments                           0 0 0 (5) (5)
Net loss                           $ 0 0 (16,007) 0 (16,007)
Balances (in shares) at Mar. 31, 2021                           117,963,912        
Balances at Mar. 31, 2021                           $ 12 $ 341,116 $ (164,888) $ (5) $ 176,235